HQY
Price
$84.92
Change
+$0.31 (+0.37%)
Updated
Jun 23 closing price
Capitalization
7.1B
76 days until earnings call
Intraday BUY SELL Signals
WAY
Price
$18.41
Change
+$1.10 (+6.35%)
Updated
Jun 23 closing price
Capitalization
3.53B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HQY vs WAY

HQY vs WAY Comparison Chart in %
View a ticker or compare two or three

Which Stock Would AI Choose? HealthEquity (HQY) vs. Waystar Holding (WAY) Stock Comparison

Key Takeaways

  • HQY boasts a larger market capitalization of approximately $6.75 billion compared to WAY's $4.13 billion, indicating greater scale in the healthcare financial services space.
  • WAY has outperformed year-to-date (YTD) with +34% returns versus HQY's +13%, driven by strong revenue growth in recent quarters.
  • HQY demonstrates superior stability with a low beta of 0.26 (a measure of stock volatility relative to the market), contrasting WAY's higher price fluctuations.
  • Both stocks recently reported positive earnings surprises, with HQY showing record health savings account (HSA) growth and WAY surpassing Q1 revenue estimates.
  • Price-to-earnings (P/E) ratios are comparable at 32.5 for HQY and 35.3 for WAY (trailing twelve months, TTM), reflecting similar valuations amid healthcare tech demand.

Introduction

HealthEquity (HQY) and Waystar Holding (WAY) operate in the burgeoning healthcare technology sector, providing platforms that streamline financial aspects of medical services. HQY focuses on consumer health savings, while WAY emphasizes provider revenue cycle management. This stock comparison is relevant for investors and traders eyeing healthcare fintech opportunities, particularly amid rising demand for efficient payment and savings solutions. By examining recent performance, growth drivers, and market positioning, readers can assess relative strengths in today's dynamic market environment.

HQY Overview and Recent Performance

HealthEquity, Inc. (HQY) delivers technology-enabled platforms for health savings accounts (HSAs) and related healthcare spending tools to consumers and employers. With over 16 million accounts under management, the company benefits from steady HSA adoption trends. In recent market activity, HQY shares have traded around $80, reflecting resilience with a 52-week range of $73 to $117. Year-to-date gains stand at about 13%, supported by record HSA growth and strong Q4 results, including revenue up 7% and improved net income per share. Positive sentiment stems from platform expansions and a new board appointment, bolstering long-term growth prospects despite broader sector pressures.

WAY Overview and Recent Performance

Waystar Holding Corp. (WAY) offers cloud-based software for healthcare payments, including financial clearance and patient billing solutions, processing billions in claims annually. The platform aids providers in revenue cycle management. Recently, WAY shares hovered near $21.50, within a 52-week range of $20 to $43, after a sharp intraday drop amid high volume. Despite this, YTD performance reached +34%, fueled by Q1 revenue beats and double-digit growth. Innovations like AI-powered tools have enhanced sentiment, though volatility reflects post-earnings reactions and market rotations in healthcare tech.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases the top 25 performers selected from 351 total AI trading bots, curated for current market conditions like volatility and sector momentum. These bots, employing diverse strategies across timeframes from 1 day to 50 days, deliver impressive stats: annualized returns ranging from +24% to +164%, win rates of 51% to 88%, and profit factors up to 11.7. They trade thousands of tickers in areas like semiconductors, AI infrastructure, ETFs, and finance, generating real-time signals for copy trading. Examples include bots focusing on NVDA and AMD for semis or leveraged ETFs like TECL. Explore these high-performing tools to enhance your trading edge.

Head-to-Head Comparison

Both HQY and WAY target healthcare financial tech, but diverge in focus: HQY’s consumer-oriented HSAs drive custodial fee revenue, while WAY’s provider tools emphasize transaction processing. Growth drivers differ, with WAY showing faster YTD momentum from revenue cycle demand, versus HQY’s steady asset accumulation. Recent momentum favors WAY on earnings beats, but HQY edges in stability (beta 0.26 vs. higher volatility). Risk factors include regulatory shifts for both, though HQY’s larger scale offers resilience. Sector exposure is pure healthcare services, with neutral sentiment post-earnings.

Tickeron AI Verdict

Tickeron’s AI models currently lean toward HQY due to its trend consistency, low volatility, and robust HSA catalysts positioning it favorably amid market rotations. WAY offers higher upside potential from growth but trails in relative stability. This probabilistic edge reflects observable momentum and risk-adjusted metrics, aiding traders in healthcare fintech positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

VS
HQY vs. WAY commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HQY is a Hold and WAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (HQY: $84.92 vs. WAY: $18.41)
Brand notoriety: HQY and WAY are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: HQY: 101% vs. WAY: 139%
Market capitalization -- HQY: $7.1B vs. WAY: $3.53B
HQY [@Services to the Health Industry] is valued at $7.1B. WAY’s [@Services to the Health Industry] market capitalization is $3.53B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $25.94B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HQY’s FA Score shows that 0 FA rating(s) are green whileWAY’s FA Score has 0 green FA rating(s).

  • HQY’s FA Score: 0 green, 5 red.
  • WAY’s FA Score: 0 green, 5 red.
According to our system of comparison, both HQY and WAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HQY’s TA Score shows that 4 TA indicator(s) are bullish while WAY’s TA Score has 3 bullish TA indicator(s).

  • HQY’s TA Score: 4 bullish, 4 bearish.
  • WAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HQY is a better buy in the short-term than WAY.

Price Growth

HQY (@Services to the Health Industry) experienced а -0.86% price change this week, while WAY (@Services to the Health Industry) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.89%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -13.14%.

Reported Earning Dates

HQY is expected to report earnings on Sep 08, 2026.

WAY is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Services to the Health Industry (-1.89% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HQY($7.1B) has a higher market cap than WAY($3.53B). HQY has higher P/E ratio than WAY: HQY (31.69) vs WAY (25.84). HQY YTD gains are higher at: -7.303 vs. WAY (-43.786). HQY has higher annual earnings (EBITDA): 508M vs. WAY (413M). HQY has more cash in the bank: 265M vs. WAY (159M). HQY has less debt than WAY: HQY (985M) vs WAY (1.49B). HQY has higher revenues than WAY: HQY (1.34B) vs WAY (1.16B).
HQYWAYHQY / WAY
Capitalization7.1B3.53B201%
EBITDA508M413M123%
Gain YTD-7.303-43.78617%
P/E Ratio31.6925.84123%
Revenue1.34B1.16B116%
Total Cash265M159M167%
Total Debt985M1.49B66%
FUNDAMENTALS RATINGS
HQY: Fundamental Ratings
HQY
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HQYWAY
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 14 days ago
74%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HQY
Daily Signal:
Gain/Loss:
WAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CALF49.120.17
+0.34%
Pacer US Small Cap Cash Cows 100 ETF
IBND31.02-0.10
-0.32%
State Street® SPDR® Blmbg Intl CorpBdETF
IAUG30.04-0.11
-0.37%
Innovator Intl Dev Pwr Bffr ETF - Aug
ENOR32.35-0.41
-1.25%
iShares MSCI Norway ETF
FUTG3.54-0.16
-4.37%
Leverage Shares 2X Long Futu Daily ETF

HQY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HQY has been loosely correlated with EVCM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HQY jumps, then EVCM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HQY
1D Price
Change %
HQY100%
+0.37%
EVCM - HQY
47%
Loosely correlated
+1.26%
CPAY - HQY
46%
Loosely correlated
-2.25%
HUBS - HQY
46%
Loosely correlated
+0.28%
ALKT - HQY
43%
Loosely correlated
+3.15%
PCOR - HQY
43%
Loosely correlated
-0.15%
More